Bioinformatics Vol. 19 no. 16 2003
pages 2065-2071
© 2003 Oxford University Press
Venn Mapping: clustering of heterologous microarray data based on the number of co-occurring differentially expressed genes
1 Department of Pathology and 2 Department of Urology, Josephine Nefkens Institute, Erasmus MC, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands
Received on November 5, 2002
; revised on March 10, 2003
; accepted on May 3, 2003
Motivation: To evaluate microarray data, clustering is widely used to group biological samples or genes. However, problems arise when comparing heterologous databases. As the clustering algorithm searches for similarities between experiments, it will most likely first separate the data sets, masking relationships that exist between samples from different databases.
Results: We developed a program, Venn Mapper, to calculate the statistical significance of the number of co-occurring differentially expressed genes in any of the two experiments. For proof of principle, we analysed a heterologous data set of 170 microarrays including breast and prostate cancer microarray analyses. Significant overlap was found in an unsupervised analysis between metastasized prostate cancer and metastasized breast cancer and BRCA mutated breast cancer. A comparison between single microarray data and the averaged breast and prostate data sets was also evaluated. This analysis suggests that genes expressed higher in stromal cells are also implicated in metastatic prostate cancer and BRCA mutated breast cancer. The Venn Mapper program identifies overlaps between samples from heterologous data sets and directly extracts the genes responsible for the overlap. From this information novel biological hypotheses may be addressed.
Availability: Venn Mapper is freely available on http://www.erasmusmc.nl/gatcplatform
Supplementary information: http://www.erasmusmc.nl/gatcplatform/vennmapper.html
Contact: g.jenster{at}erasmusmc.nl
* To whom correspondence should be addressed.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. J.M. Hendriksen, N. F.J. Dits, K. Kokame, A. Veldhoven, W. M. van Weerden, C. H. Bangma, J. Trapman, and G. Jenster Evolution of the Androgen Receptor Pathway during Progression of Prostate Cancer. Cancer Res., May 15, 2006; 66(10): 5012 - 5020. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hirao, S. Arakawa, K. Watanabe, K. Ito, and T. Furukawa Effects of Restricted Feeding on Daily Fluctuations of Hepatic Functions Including P450 Monooxygenase Activities in Rats J. Biol. Chem., February 10, 2006; 281(6): 3165 - 3171. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Dhahbi, P. L. Mote, G. M. Fahy, and S. R. Spindler Identification of potential caloric restriction mimetics by microarray profiling Physiol Genomics, November 17, 2005; 23(3): 343 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hanifi-Moghaddam, S. C. J. P. Gielen, H. J. Kloosterboer, M. E. De Gooyer, A. M. Sijbers, A. J. van Gool, M. Smid, M. Moorhouse, F. H. van Wijk, C. W. Burger, et al. Molecular Portrait of the Progestagenic and Estrogenic Actions of Tibolone: Behavior of Cellular Networks in Response to Tibolone J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 973 - 983. [Abstract] [Full Text] [PDF] |
||||



